SAFUSIDENIB
UNII RCK8KK7SB9

Substance Identification & Data

This profile provides standardized clinical and technical data for Safusidenib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RCK8KK7SB9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1898206-17-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RCK8KK7SB9

CAS Registry Number

1898206-17-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SAFUSIDENIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H18Cl3FN2O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BOOMBLZEOHXPPX-BQYQJAHWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C148134

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

130306983

Unique identification number in the NCBI database of chemical substances.

INN ID

11941

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(=O)(c1c(noc1C(C)(C)F)-c2c(Cl)cc(Cl)cc2Cl)n3c4c(c(C)c3)c(/C=C/C(O)=O)ccc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Safusidenib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.